As part of the Experimental Medicine Training Initiative, this is a prestigious fully-funded, Clinical PhD Studentship at the University of Cambridge. This innovative initiative is a partnership between the University of Cambridge, Cambridge Biomedical Research Centre and Pharmaceutical Companies. The Studentship is available from April 2018, and provides an unrivalled opportunity to undertake high quality clinical research in the area of nephrology and clinical pharmacology, in collaboration with AstraZeneca. It will appeal to clinical trainees from a wide range of disciplines including Clinical Pharmacology, Nephrology and Acute Medicine. The Studentship award will cover a clinical stipend for 3 years, University and College fees, and a generous training allowance. This project is a unique opportunity to join a collaboration between the Division of Experimental Medicine and Immunotherapeutics at the University of Cambridge, and the Renal division at AstraZeneca.
The remit will be to study the epidemiology, sequelae and treatment of hyperkalaemia with particular reference to the emergency setting. Existing treatments have important limitations. Novel treatment options exist and the studentship will be focused on the design and conduct of epidemiological, physiological and proof of concept studies to develop novel approaches to the emergency management of hyperkalaemia. Working closely with leading investigators in the Division of Experimental Medicine and Immunotherapeutics from the University of Cambridge, the Cambridge Clinical Trials Unit and AstraZeneca, you will apply the findings of these studies to the design of a late phase emergency medicine trial.
This project will provide you with an opportunity to apply your strengths to emergency, renal and experimental medicine, and will provide a unique hands-on perspective of translational medicine. The successful applicant will be offered the opportunity to spend time with AstraZeneca and international academic collaborators. The structured mentoring and training environment will allow the candidate to develop as an academic clinician with expertise in designing and conducting experimental medicine studies and later phase trials.
It is essential that the applicant is fully registered with the GMC, and desirable that they already hold a National Training Number. They must successfully complete an application to the Department of Medicine PhD course, at the University of Cambridge.
For general queries on the Experimental Medicine Training Initiative please contact Professor Ian Wilkinson (Director of the EMI), on 01223 336 806; interested candidates are encouraged to contact Dr Thomas Hiemstra (01223 336 817 or via email email@example.com) for informal enquiries.
For further information go to: http://cato.medschl.cam.ac.uk/graduate-programmes/phd-programmes/experimental-medicine-training-initiative-emi/
Fixed-term: The funds for this post are available for 3 years in the first instance.
This appointment requires an Honorary Clinical Contract.
To apply online for this vacancy, please click on the 'Apply' button below. This will route you to the University's Web Recruitment System, where you will need to register an account (if you have not already) and log in before completing the online application form.
Please ensure that you upload a covering letter, CV, list of publications, current and future research plans (two sides of A4 only) and the Clinical Research Associate additional information form in the upload section of the online application. If you upload any additional documents which have not been requested, we will not be able to consider these as part of your application.
Please include details of your referees, including email address and phone number, one of which must be your most recent line manager.
Deadline for applications is the 4th March 2018 with interviews likely to take on the 16th March 2018.
Please quote reference RC14549 on your application and in any correspondence about this vacancy.
The University values diversity and is committed to equality of opportunity.
The University has a responsibility to ensure that all employees are eligible to live and work in the UK.